These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features. van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG. J Med Chem; 2011 Oct 27; 54(20):7030-54. PubMed ID: 21866910 [Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists. Yoo E, Hayat F, Rhim H, Park Choo HY. Bioorg Med Chem; 2012 Apr 15; 20(8):2707-12. PubMed ID: 22405919 [Abstract] [Full Text] [Related]
10. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists. Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I. Eur J Med Chem; 2011 Apr 15; 46(4):1189-97. PubMed ID: 21333408 [Abstract] [Full Text] [Related]
11. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists. Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR. Bioorg Med Chem Lett; 2002 May 20; 12(10):1357-60. PubMed ID: 11992776 [Abstract] [Full Text] [Related]
12. Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists. Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM. J Med Chem; 2011 Dec 08; 54(23):8161-73. PubMed ID: 22029285 [Abstract] [Full Text] [Related]